Block Listing

Hikma Pharmaceuticals Plc
03 April 2006

3 April 2006

Block Listing of Shares



                           Hikma Pharmaceuticals PLC




Hikma Pharmaceuticals PLC (the 'Company') announces that it has made a block
listing application to the UK Listing Authority and the London Stock Exchange
for a total of 4,058,400 ordinary shares of 10p each in the capital of the
Company to be admitted to the Official List of the UK Listing Authority and
admitted to trading on the main market of the London Stock Exchange.



The shares, when issued, will be issued fully paid and rank pari passu in all
respects with the existing issued ordinary shares of the Company.  The shares
may be issued pursuant to the exercise of options under the Hikma
Pharmaceuticals PLC 2004 Stock Option Plan (the 'Plan'). Participants in the
Plan have or will become entitled to these shares following the vesting and
exercise of options over shares.



It is expected that admission will be granted on 4 April 2006.



For further information, please contact:



Henry Knowles, Company Secretary
Hikma Pharmaceuticals PLC                                     [phone]



Susan Ringdal, Investor Relations Director

Hikma Pharmaceuticals PLC                                     [phone]










About Hikma



Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products.  Hikma's operations
are conducted through three businesses: Generic, Branded and Injectable
Pharmaceuticals.  Hikma's operations are based principally in the United States,
the Middle East and North Africa ('MENA') region and Europe.  In 2005, the Group
had revenue of $262 million and profit attributable to shareholders of $44
million.  At 31 December 2005, the Group had over 1,800 employees.  For news and
other information, please visit www.hikma.com.




                      This information is provided by RNS
            The company news service from the London Stock Exchange